Aurum Biosciences Ltd
PrivateLast Round
Series A
Jul 11, 2026
Total Funding Raised
$5.43M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Aurum Biosciences Ltd operates in Healthcare & Life Sciences and is based in Glasgow. Its latest recorded funding round was a Seed round in January 2024.
Aurum Biosciences Ltd is a clinical-stage biopharmaceutical company that develops novel oxygen carriers for use as therapeutics and diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Imaging, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aurum Biosciences Ltd Comparables
Compare Aurum Biosciences Ltd with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prolong Pharmaceuticals, LLC | 83% | |
| NuvOx Therapeutics | 80% | |
| Fluoro2 Therapeutics | 76% |
For institutional investors. Book with your work email.
Aurum Biosciences Ltd Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 11, 2026 | ||||
| Seed | Jan 24, 2024 | ||||
| VC Round | Oct 12, 2020 | ||||
| Seed | Nov 13, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aurum Biosciences Ltd Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InnoScot Health | VC Round, Seed |
| The TRICAPITAL Syndicate | VC Round, Seed |
| Scottish National Investment Bank | VC Round, Seed |
| Scottish Investment Bank (Scottish Enterprise) | VC Round, Seed |
| Wellcome Trust | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 56% MoM.
- Jul 11, 2026
$13M round completed.
For institutional investors. Book with your work email.
Aurum Biosciences Ltd Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aurum Biosciences Ltd's valuation, stock price, and market status.
Is Aurum Biosciences Ltd a public or private company?
Aurum Biosciences Ltd is a private company.
What is the current stock price of Aurum Biosciences Ltd?
Aurum Biosciences Ltd is a private company, so its shares have no public market price. Caplight tracks Aurum Biosciences Ltd's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aurum Biosciences Ltd worth (valuation)?
Valuation information for Aurum Biosciences Ltd is not publicly available.
Can I buy Aurum Biosciences Ltd stock?
Aurum Biosciences Ltd shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aurum Biosciences Ltd's last funding round?
Aurum Biosciences Ltd's most recent funding round was Series A on July 11, 2026.
Who are the main investors in Aurum Biosciences Ltd?
Key investors in Aurum Biosciences Ltd include InnoScot Health.
Will Aurum Biosciences Ltd IPO soon?
No public IPO plans have been announced for Aurum Biosciences Ltd.
How can I track Aurum Biosciences Ltd secondary market activity?
Caplight tracks bids, offers, and trades in Aurum Biosciences Ltd's shares on secondary markets.